K-numberK243600
Device name3nethra neo HD FA; 3nethra neo HD
ApplicantForus Health Pvt.Ltd
Product codeHKI
Device classClass II
Decision dateAug 14, 2025
DecisionSubstantially Equivalent
Regulation886.1120
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The 3nethra neo HD FA and 3nethra neo HD are handheld wide-angle fundus imaging systems for neonatal screening. They acquire, display, store, and transmit images of the posterior and anterior eye surfaces to document ocular diseases in infants, particularly retinopathy of prematurity (ROP). The devices provide image acquisition only and do not perform pathological analysis or diagnosis.

Technological characteristics

Both subject devices use white and blue LED light sources with software-controlled motorized blue filters and operate at AC 100–240 V, 50/60 Hz. The 3nethra neo HD FA includes a fluorescence angiography (FFA) module with blue light source and green filters; the 3nethra neo HD lacks this feature. Both achieve 150-degree field of view compared to the predicate's 120 degrees, and output images in PNG/JPEG/DCM formats. Both comply with IEC 60601-1 and IEC 60601-1-2 safety standards.

Test standards cited

IEC 60601-1 (electrical safety), IEC 60601-1-2 (electromagnetic compatibility), ISO 15004-2 (ophthalmic instruments fundamental requirements and test methods), and ANSI Z80.36 (light safety for ophthalmic instruments). Testing demonstrated Group 1 instrument classification compliance.

Substantial equivalence argument

The subject devices are substantially equivalent because their intended use, design methodology, and operating principles are identical to the primary predicate (3nethra neo, K183059), which is a device manufactured by the same applicant. The FFA capability in the HD FA variant mirrors the reference device (RetCam 3, K102859), which includes fluorescence angiography. All key technological characteristics—light sources, power supply, imaging formats, and safety compliance—match or exceed predicate specifications. Bench testing confirms electrical safety and EMC compliance, and clinical image quality comparison to the RetCam 3 demonstrated comparable performance. The patient-contact surface is identical to the primary predicate, eliminating biocompatibility concerns.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →